KeyCorp Comments on Sartorius Aktiengesellschaft’s Q2 2022 Earnings (OTCMKTS:SARTF)

Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Rating) – KeyCorp decreased their Q2 2022 earnings per share estimates for Sartorius Aktiengesellschaft in a report released on Thursday, April 21st. KeyCorp analyst P. Knight now forecasts that the company will post earnings of $2.44 per share for the quarter, down from their prior forecast of $2.55. KeyCorp also issued estimates for Sartorius Aktiengesellschaft’s Q3 2022 earnings at $2.48 EPS, Q4 2022 earnings at $2.80 EPS, FY2022 earnings at $10.37 EPS and FY2024 earnings at $13.72 EPS.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Rating) last issued its quarterly earnings results on Thursday, April 21st. The company reported $2.74 EPS for the quarter, beating the Zacks’ consensus estimate of $2.49 by $0.25. Sartorius Aktiengesellschaft had a return on equity of 34.63% and a net margin of 11.99%. The company had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.06 billion.

Several other research firms have also recently weighed in on SARTF. Societe Generale raised shares of Sartorius Aktiengesellschaft from a “hold” rating to a “buy” rating in a report on Friday, January 28th. Berenberg Bank upgraded shares of Sartorius Aktiengesellschaft from a “hold” rating to a “buy” rating in a research report on Wednesday, April 13th. Finally, UBS Group upgraded shares of Sartorius Aktiengesellschaft from a “sell” rating to a “neutral” rating in a research report on Friday, April 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $776.00.

OTCMKTS:SARTF opened at $369.80 on Monday. Sartorius Aktiengesellschaft has a 1 year low of $329.00 and a 1 year high of $947.00. The stock’s fifty day moving average price is $380.77 and its two-hundred day moving average price is $493.20. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.16 and a quick ratio of 0.58. The company has a market cap of $12.66 billion, a P/E ratio of 49.37 and a beta of 0.62.

About Sartorius Aktiengesellschaft (Get Rating)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents.

Further Reading